LFCM
Long Focus Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.3M | Buy |
11,820,000
+2,569,945
| +28% | +$4.42M | 0.77% | 27 |
|
|
2025
Q1 | $30.8M | Buy |
9,250,055
+4,118,055
| +80% | +$13.7M | 1.03% | 14 |
|
|
2024
Q4 | $38M | Buy |
5,132,000
+600,000
| +13% | +$4.44M | 1.23% | 9 |
|
|
2024
Q3 | $42.6M | Buy |
4,532,000
+400,000
| +10% | +$3.76M | 1.49% | 8 |
|
|
2024
Q2 | $33.1M | Buy |
4,132,000
+2,731,688
| +195% | +$21.9M | 1.27% | 8 |
|
|
2024
Q1 | $20.8M | Sell |
1,400,312
-735,209
| -34% | -$10.9M | 1.06% | 10 |
|
|
2023
Q4 | $17.4M | Sell |
2,135,521
-335,000
| -14% | -$2.72M | 0.58% | 10 |
|
|
2023
Q3 | $11.2M | Buy |
2,470,521
+593,707
| +32% | +$2.7M | 0.4% | 21 |
|
|
2023
Q2 | $13.2M | Sell |
1,876,814
-185,000
| -9% | -$1.3M | 0.6% | 15 |
|
|
2023
Q1 | $12.6M | Hold |
2,061,814
| – | – | 0.71% | 16 |
|
|
2022
Q4 | $13.2M | Buy |
2,061,814
+1,125,814
| +120% | +$7.19M | 0.91% | 13 |
|
|
2022
Q3 | $8.97M | Sell |
936,000
-689,000
| -42% | -$6.6M | 0.87% | 16 |
|
|
2022
Q2 | $17.9M | Buy |
1,625,000
+920,000
| +130% | +$10.2M | 1.88% | 6 |
|
|
2022
Q1 | $11.7M | Buy |
705,000
+180,000
| +34% | +$3M | 1.51% | 10 |
|
|
2021
Q4 | $10M | Buy |
+525,000
| New | +$10M | 1.33% | 8 |
|